Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Reintroduced Humane Cosmetics Act Mum On FDA’s Role

This article is powered by The Rose Sheet

Executive Summary

While the previous session’s iteration of the Humane Cosmetics Act attracted support from nearly 40% of the House, it did not advance – a fate sponsors hope to avoid with broad bipartisan support and assurances that the bill would not hurt businesses.


Related Content

CFI Sets Sights On US, Global Bans To ‘Close The Door’ On Cosmetic Animal Testing
California’s Advancing Cosmetic Animal-Test Ban Poses Liabilities, Industry Says
US States Exploring Cosmetic Animal-Testing Bans With Federal Movement Stalled
PCPC’s Global Priorities: A Q&A With Executive VP Francine Lamoriello
The Body Shop Seeks Global End To Animal Testing Through UN Petition
US Humane Cosmetics Act Expected Soon, House Reps Say
Landmark EU Ruling: Animal-Tested Cosmetic Ingredients Not Banned Per Se
Bipartisan Support Could Propel U.S. Bill To Ban Cosmetic Animal Testing


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts